Hercules Technology Growth Capital, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Hercules Technology Growth Capital, Inc. on October 2, 2015. The report covers a specific event occurring on the same date regarding a portfolio company milestone.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this filing. The document solely announces a corporate event involving a portfolio company.
Outlook, Commentary, and Risks
Management Commentary: The company issued a press release congratulating Edge Therapeutics, Inc. on its initial public offering (IPO).
Risks and Contingencies: No specific risks, contingencies, or unusual items are disclosed in this filing.
Key Facts for Investor Verification
- Portfolio company Edge Therapeutics, Inc. completed an initial public offering on October 2, 2015.
- The filing serves as a notification of this event and includes the associated press release as Exhibit 99.1.
- No financial data or operational updates for Hercules Technology Growth Capital, Inc. are included in this specific report.